Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.
Choroidal neovascular membrane (CNVM) formation is a well-documented sight-threatening complication of posterior segment intraocular inflammation (PSII). The aim of this article is to review the basic and clinical science literature on the pathogenesis of CNVM formation in PSII and to present results of a case series. We searched the literature using the mesh terms- inflammation, CNVM, age-related macular degeneration, immunosuppression, photodynamic therapy, steroids, vascular endothelial growth factors and posterior uveitis. Additionally, we evaluated the visual outcome of and clinical response to our standard treatment protocol involving a combination treatment for young patients with inflammatory CNVM. The development of CNVM in PSII is promulgated by infiltrating myeloid cells as well as choroidal and retinal myeloid cell activation, subsequent vascular endothelial growth factors, cytokine and chemokine production and complement activation acting in consort to mediate angiogenic responses. No clear standard of care currently exists for the treatment of inflammatory CNVM and various combinations have been tried. Using our combination treatment, visual acuity improved in four, stabilized in one and worsened in four patients. Though significant advances have occurred in the understanding of the pathogenesis and management of this condition, optimizing therapeutic regimens will require further well-constructed prospective cohort series.
Dhingra
Narendra
N
Department of Academic Ophthalmology, Bristol Eye Hospital, Bristol, United Kingdom.
Kelly
Susan
S
Majid
Mohammed A
MA
Bailey
Claire B
CB
Dick
Andrew D
AD
D000818:Animals; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D017075:Laser Coagulation / Q000379:methods*; D013508:Ophthalmologic Surgical Procedures / Q000379:methods*; D010789:Phototherapy / Q000379:methods*; D011379:Prognosis; D015866:Uveitis, Posterior / Q000150:complications*
D005938:Glucocorticoids